Tryptamine analogues, their synthesis and their use as 5-HT.sub.1 -like
申请人:SmithKline Beecham plc
公开号:US05571833A1
公开(公告)日:1996-11-05
The present invention relates to known and novel tryptamine analogues, processes and intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy, in particular for the treatment and/or prophylaxis of disorders characterized by excessive vasodilatation, such as migraine and portal hypertension.